Balyasny Asset Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Balyasny Asset Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-67,599	Closed	-$899	–	2888
2023 Q2	$899	Sell	67,599 -23,351	-26%	-$722	﹤0.01%	2211
2023 Q1	$4.64K	Hold	90,950	–	–	﹤0.01%	2551
2022 Q4	$8.81K	Hold	90,950	–	–	﹤0.01%	2572
2022 Q3	$20K	Hold	90,950	–	–	﹤0.01%	2586
2022 Q2	$20K	Sell	90,950 -59,050	-39%	-$47.6K	﹤0.01%	2488
2022 Q1	$115K	Sell	150,000 -50,000	-25%	-$36.6K	﹤0.01%	2122
2021 Q4	$240K	Hold	200,000	–	–	﹤0.01%	1793
2021 Q3	$202K	Hold	200,000	–	–	﹤0.01%	1646
2021 Q2	$218K	Hold	200,000	–	–	﹤0.01%	1713
2021 Q1	$174K	Buy	+200,000	New	+$208K	﹤0.01%	1591

Balyasny Asset Management's GRNAW Position: Q3 2023 in Review

Balyasny Asset Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 67,599 shares — an estimated $899 sold.

Balyasny Asset Management first reported a position in GRNAW in Q1 2021 and held it in 10 quarters. The position peaked at $240K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Balyasny Asset Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Balyasny Asset Management sold 67,599 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $899.
Balyasny Asset Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 10 quarters.
Balyasny Asset Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $240K in Q4 2021.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Balyasny Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.